Package 72865-316-60

{"route": ["ORAL"], "spl_id": "297988b4-69fb-4691-92e0-ee5da80b0125", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0372865314104", "0372865315606", "0372865313602", "0372865315101", "0372865313107", "0372865316108", "0372865314609", "0372865316603"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_set_id": ["546103e1-ea6e-466b-b0de-b1ff8c494512"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["XLCare Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (72865-316-10)", "package_ndc": "72865-316-10", "marketing_start_date": "20250710"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (72865-316-60)", "package_ndc": "72865-316-60", "marketing_start_date": "20250710"}], "brand_name": "TOPIRAMATE", "product_id": "72865-316_297988b4-69fb-4691-92e0-ee5da80b0125", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72865-316", "generic_name": "Topiramate", "labeler_name": "XLCare Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TOPIRAMATE", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "200 mg/1"}], "application_number": "ANDA215414", "marketing_category": "ANDA", "marketing_start_date": "20250710", "listing_expiration_date": "20261231"}